Back to search results

[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Recurrent High-Grade Gliomas · Recurrent Glioblastoma IDH Wildtype

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Li'ao Wang, M.D.) · wangliao17@163.com · 15001171671
    Contact: Principal Investigator (Deling Li, M.D.)

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Zhaohui Zhu, M.D.) · 13611093752@163.com · +86 15909835868
    Contact: Principal Investigator (Zhaohui Zhu, M.D.)
Study leads

  • Deling Li, M.D.

    Principal Investigator

    Beijing Tiantan Hospital

  • Zhaohui Zhu

    Principal Investigator

    Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

View source on ClinicalTrials.gov(opens in a new tab)